Contingency Management Treatment for Crack Addiction - Study With Brazilian Population
Evaluating the Efficacy of Including Contingency Management to Standard Ambulatory Treatment for Crack Addiction - A Randomized Controlled Trial
1 other identifier
interventional
65
1 country
1
Brief Summary
Crack addiction has become a severe health problem in Brazil. Today, crack addiction is the primary cause for inpatient treatment for all illicit substances. When compared to cocaine, crack users develop much faster diagnoses for crack dependence, shows a more compulsive pattern of use, has higher probability of living or have lived in the streets, and of engaging in illegal activities. Consequently to this, mortality of crack addicts is 7 times higher than for the rest of the population. Despite all efforts being made for the development of effective pharmacological treatments for stimulant addiction (crack included), up to today, there is no robust evidence of efficacy of any pharmacological treatment. For that reason, the use of evidence based psychosocial interventions is so important for treating this population. Although today open treatment facilities in Brazil are more and more starting to use evidence-based interventions such as motivational interviewing, cognitive behavior therapy, relapse prevention and coping skills, such treatments present very modest results when treating crack addiction. The biggest difficulties encountered when treating this population are maintaining patients in treatment, reducing crack use and achieving continued abstinence. A psychosocial treatment based in behavioral principals' named Contingency Management (CM) is widely applied in the USA. Recent meta-analyses and review studies present robust evidence that, when applied alone or in adjunction with other psychosocial and pharmacological treatment, CM is the most effective treatment for what regards, treatment retention, reducing drug use and promoting continued abstinence. The purpose of this study is to evaluate if Contingence Management (CM) can be affective in the treatment of crack addiction in Brazil. To accomplish this, 60 individuals (male and female from 18 to 65 years of age) seeking open treatment for crack addiction will be randomized to 2 treatment conditions (Standard treatment (ST) or ST+CM. Both treatments will last 12 weeks with 3 and 6-month follow-up. In both groups patients will be encourage to leave urine samples 3 times week. Hypotheses: Patients receiving ST+CM will stay longer in treatment, have more negative tests for cocaine/crack, and achieve longer periods of cocaine/crack abstinence when compared to patients receiving ST alone.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2012
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2012
CompletedFirst Submitted
Initial submission to the registry
March 18, 2013
CompletedFirst Posted
Study publicly available on registry
March 21, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2015
CompletedResults Posted
Study results publicly available
June 19, 2017
CompletedJuly 27, 2017
July 1, 2017
3.1 years
March 18, 2013
August 10, 2015
July 26, 2017
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Longest Duaration of Achieved Abstinance
Number of Participants with 4, 8 and 12 Weeks Continued Abstinence
12 weeks of treatment
Percentage Samples Submitted Negative for Crack Cocaine Use
Proportion of samples testing negative for Crack Cocaine use
12 weeks
Number of Participants Completing 4, 8 and 12 Weeks of Treatment
Retention in treatment was quantified as the period elapsed between treatment intake and dropout (last appearance at the treatment facility) or the end of treatment. We present data on the number of participants retained in treatment in weeks 4, 8 and 12.
Number of participant retained in treatment at weeks 4, 8 and 12.
Treatment Attendance
Treatment attendance was expressed as the total number of sessions attended during the 12 weeks of treatment.
12 weeks
Secondary Outcomes (2)
Percentage Samples Submitted Negative for Alcohol Use
12 weeks
Percentage Samples Submitted Negative for Marihuana Use
12 weeks
Study Arms (2)
Standard treatment Alone
ACTIVE COMPARATORParticipants in the Standard Treatment Alone group will receive 12 weeks of the exact treatment provided by the Ambulatory service where the study is being conducted
ST+CM
EXPERIMENTALParticipants in the Standard treatment plus Contingency Management (ST+CM) group will receive 12 weeks of the exact treatment provided by the Ambulatory service where the study is being conducted plus CM.
Interventions
12 weeks of the standard treatment offered by a open treatment service for drug addiction of the city of Sao Paulo (AME) plus Contingency Management
12 weeks of standard treatment offered by AME (a open treatment service for drug addiction of the city of Sao Paulo)
Eligibility Criteria
You may qualify if:
- Current diagnose of crack addiction (DSM IV)
- having used crack in the last month
You may not qualify if:
- Current psychotic disorder
- Diagnose of schizophrenia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ambulatorio Medico de Especialidades (AME) da Vila Maria
São Paulo, São Paulo, Brazil
Related Publications (3)
Miguel AQ, Madruga CS, Cogo-Moreira H, Yamauchi R, Simoes V, da Silva CJ, McPherson S, Roll JM, Laranjeira RR. Contingency management is effective in promoting abstinence and retention in treatment among crack cocaine users in Brazil: A randomized controlled trial. Psychol Addict Behav. 2016 Aug;30(5):536-543. doi: 10.1037/adb0000192. Epub 2016 Jul 21.
PMID: 27442691BACKGROUNDde Queiroz Constantino Miguel A, Sandi Madruga C, Simoes V, Yamauchi R, da Silva CJ, McDonell M, McPherson S, Roll J, Laranjeira RR, de Jesus Mari J. Contingency management is effective in promoting abstinence and retention in treatment among crack cocaine users with a previous history of poor treatment response: a crossover trial. Psicol Reflex Crit. 2019 Jul 15;32(1):14. doi: 10.1186/s41155-019-0127-2.
PMID: 32026092DERIVEDMiguel AQC, Madruga CS, Cogo-Moreira H, Yamauchi R, Simoes V, Ribeiro A, da Silva CJ, Fruci A, McDonell M, McPherson S, Roll JM, Laranjeira RR. Contingency management targeting abstinence is effective in reducing depressive and anxiety symptoms among crack cocaine-dependent individuals. Exp Clin Psychopharmacol. 2017 Dec;25(6):466-472. doi: 10.1037/pha0000147.
PMID: 29251975DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Andre Q. C. Miguel
- Organization
- Federal University of Sao Paulo
Study Officials
- PRINCIPAL INVESTIGATOR
Ronaldo R Laranjeira, PhD
EPM/UNIFESP
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Both participants and researchers know the treatment alocations
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Ph.D Studant
Study Record Dates
First Submitted
March 18, 2013
First Posted
March 21, 2013
Study Start
May 1, 2012
Primary Completion
June 1, 2015
Study Completion
June 1, 2015
Last Updated
July 27, 2017
Results First Posted
June 19, 2017
Record last verified: 2017-07
Data Sharing
- IPD Sharing
- Will not share